Centro Nacional de Investigaciones Oncológicas

Centro Nacional de Investigaciones Oncológicas
Name	Centro Nacional de Investigaciones Oncológicas
Native name	Centro Nacional de Investigaciones Oncológicas Carlos III
Established	1998
Type	Research institute
Location	Madrid, Spain
Affiliations	Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación

Centro Nacional de Investigaciones Oncológicas. The Centro Nacional de Investigaciones Oncológicas is a Spanish national cancer research institute located in Madrid, founded in the late 20th century with ties to Instituto de Salud Carlos III, the Ministerio de Ciencia e Innovación (España), and European research frameworks such as Horizon 2020, European Research Council, and COST (European Cooperation in Science and Technology). It functions as a nexus between translational research, clinical oncology centers like Hospital Universitario Doce de Octubre, and international institutions including Institut Gustave Roussy, Memorial Sloan Kettering Cancer Center, Dana–Farber Cancer Institute, and the German Cancer Research Center.

History

The institute was created amid Spanish science policy reforms associated with the Instituto de Salud Carlos III expansion, paralleling developments at Centro Nacional de Microbiología, Centro Nacional de Investigaciones Cardiovasculares (CNIC), and other national centers. Early leadership drew on figures from Universidad Complutense de Madrid, Universidad Autónoma de Madrid, and clinical departments at Hospital Universitario La Paz, while programmatic links formed with European Molecular Biology Laboratory, EMBL, and the Wellcome Trust. During the 2000s the institute expanded infrastructure supported by projects connected to Severo Ochoa-style excellence frameworks and national science initiatives coordinated by the Ministerio de Ciencia e Innovación (España), aligning with networks such as EATRIS, ESFRI, and the European Cancer Organisation.

Mission and organization

The institute's mission emphasizes basic, translational, and clinical oncology research, integrating units inspired by models from Francis Crick Institute, Broad Institute, and Cold Spring Harbor Laboratory. Its organizational structure includes research programs, core facilities, biobanks, and a clinical oncology unit that coordinates with Spanish National Health System, regional health services like Servicio Madrileño de Salud, and university hospitals such as Hospital General Universitario Gregorio Marañón. Governance involves oversight by the Ministerio de Ciencia e Innovación (España), advisory boards with representatives from European Commission, and partnerships with funding agencies like Fondo Europeo de Desarrollo Regional, Carlos III Health Institute, and philanthropic organizations akin to Fundación CRIS contra el cáncer.

Research programs

Research spans molecular oncology, genomics, immuno-oncology, and cancer therapeutics, with programs comparable to those at National Cancer Institute (US), Cancer Research UK, and Institut Curie. Key areas include genome sequencing and bioinformatics using platforms developed in collaboration with European Bioinformatics Institute, Genomics England, and industrial partners such as Illumina and Thermo Fisher Scientific. Immunotherapy research draws on paradigms from James P. Allison and Tasuku Honjo-inspired checkpoint studies and coordinates trials similar to those at MD Anderson Cancer Center and Johns Hopkins Hospital. Structural biology and drug discovery efforts mirror initiatives at European Molecular Biology Laboratory and Max Planck Society, while translational pipelines engage with regulatory frameworks from the European Medicines Agency, Spanish Agency of Medicines and Medical Devices, and clinical trial consortia like EORTC.

Clinical services and patient care

Clinical services integrate multidisciplinary oncology, radiotherapy, medical oncology, and surgical oncology teams collaborating with referral centers such as Hospital Universitario 12 de Octubre, Hospital Clínic de Barcelona, and Hospital Universitario Ramón y Cajal. Patient care protocols follow evidence from NCI Clinical Trials Network and European guidelines produced by ESMO and NICE. The institute's clinical trials unit participates in phase I–III trials coordinated with consortia like EORTC, Cancer Core Europe, and pharmaceutical partners including Roche, Novartis, and Bristol Myers Squibb. Supportive care programs align with models from Macmillan Cancer Support and survivorship initiatives developed alongside World Health Organization recommendations.

Education and training

Training programs include doctoral fellowships, postdoctoral positions, and clinical residencies linked to universities such as Universidad de Alcalá, Universidad de Salamanca, and Universidad de Valencia. Continuing education initiatives collaborate with professional societies like Spanish Society of Medical Oncology, European Society for Medical Oncology, and American Society of Clinical Oncology, while summer schools and workshops mirror formats from Cold Spring Harbor Laboratory and EMBO courses. Career development awards and mobility schemes link to Marie Skłodowska-Curie Actions, Fulbright Program, and national scholarships administered by Agencia Estatal de Investigación.

Collaborations and partnerships

The institute maintains national and international collaborations with research centers including Institut Gustave Roussy, DKFZ, Francis Crick Institute, Memorial Sloan Kettering Cancer Center, and networks such as Cancer Core Europe, EORTC, and European Organization for Research and Treatment of Cancer. Industrial partnerships involve pharmaceutical and biotech companies like Roche, Novartis, Pfizer, GlaxoSmithKline, and diagnostics firms comparable to Siemens Healthineers and Roche Diagnostics. Scientific cooperation extends to consortia funded by Horizon Europe, bilateral agreements with ministries such as Ministry of Health (Spain), and engagement with patient advocacy groups similar to European Cancer Patient Coalition and national foundations such as Fundación OncoGUIA.

Category:Cancer research institutes